Guided Therapeutics (GTHP) director swaps and exercises 100,000 warrants
Rhea-AI Filing Summary
Guided Therapeutics Inc. director James Michael C reported warrant exchanges and an exercise involving the company’s common stock. In February 2026, he exchanged 100,000 warrants with a $0.65 exercise price for 100,000 new warrants with a $0.25 exercise price, then exercised the new warrants for $25,000, receiving 100,000 common shares. As part of the same agreement, the expiration date of separate 4‑year warrants for 100,000 shares with a $0.50 exercise price was extended to September 1, 2027. Following these transactions, he directly held 653,495 common shares and 52,778 warrants.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 100,000 shares
Net Buy
6 txns
Insider
JAMES MICHAEL C
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Other | Warrants | 100,000 | $0.00 | $0.00 |
| Other | Warrants | 100,000 | $0.00 | $0.00 |
| Other | Warrants | 100,000 | $0.00 | $0.00 |
| Other | Warrants | 100,000 | $0.00 | $0.00 |
| In-the-Money Exercise | Warrants | 100,000 | $0.00 | $0.00 |
| In-the-Money Exercise | Common Stock | 100,000 | $0.00 | $0.00 |
Holdings After Transaction:
Warrants — 152,778 shares (Direct);
Common Stock — 653,495 shares (Direct)
Footnotes (1)
- F1. During February 2026, Mr. James signed an exchange agreement to exchange 100,000 warrants to purchase shares of common stock with an exercise price of $0.65 for 100,000 warrants to purchase shares of common stock for an exercise price of $0.25. The newly exchanged warrants were subsequently exercised upon payment of $25,000. Moreover, as part of the exchange agreement, the expiration date of 4-year 100,000 warrants to purchase shares of common stock with exercise price of $0.50 was extended for an additional year, until September 1, 2027.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did Guided Therapeutics (GTHP) insider James Michael C do in this Form 4?
James Michael C reported exchanging and exercising warrants in Guided Therapeutics. He swapped 100,000 warrants at $0.65 for 100,000 warrants at $0.25, then exercised the new warrants for $25,000 to receive 100,000 common shares and extended other warrants’ expiration.
What warrant exchange terms were disclosed for Guided Therapeutics (GTHP)?
The Form 4 shows an exchange of 100,000 warrants with a $0.65 exercise price for 100,000 new warrants at $0.25. The newly issued warrants were then exercised, and the filing notes these actions occurred during February 2026 under an exchange agreement.
Were any Guided Therapeutics (GTHP) warrant expirations changed in this Form 4?
Yes. The filing states that 4‑year warrants for 100,000 shares with a $0.50 exercise price had their expiration extended by one year, to September 1, 2027, as part of the same exchange agreement described in the Form 4 footnote.
What are James Michael C’s holdings in Guided Therapeutics (GTHP) after these transactions?
After the reported transactions, James Michael C directly held 653,495 Guided Therapeutics common shares and 52,778 warrants. These figures reflect the warrant exchange, subsequent exercise for 100,000 shares, and the remaining derivative securities disclosed in the Form 4.
Did the Guided Therapeutics (GTHP) Form 4 report any open‑market buys or sells?
The Form 4 does not show open‑market buys or sells. It reports warrant exchanges coded as “J” and an in‑the‑money derivative exercise coded as “X,” resulting in 100,000 new common shares and changes to warrant terms and balances.